SMBT
EW icon

Southern Michigan Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Southern Michigan Bank & Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.7K Hold
649
– – 0.02% 192
2026
Q1 		$52K Buy
+649
New +$53.5K 0.02% 204

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Southern Michigan Bank & Trust's EW Position: Q2 2026 in Review

Southern Michigan Bank & Trust held its Edwards Lifesciences (EW) position steady in Q2 2026 at 649 shares worth $58.7K. The position accounts for 0.02% of the portfolio, ranked #192.

Southern Michigan Bank & Trust first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Southern Michigan Bank & Trust held 649 shares of Edwards Lifesciences worth $58.7K as of Q2 2026.
  • Southern Michigan Bank & Trust left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.02% of Southern Michigan Bank & Trust's portfolio in Q2 2026, its #192 holding.
  • Southern Michigan Bank & Trust first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Southern Michigan Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.